Cargando…

Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer

Detalles Bibliográficos
Autores principales:	Mor, Gil, Rutherford, Thomas, Alvero, Ayesha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769689/ https://www.ncbi.nlm.nih.gov/pubmed/31491839 http://dx.doi.org/10.3390/cancers11091307

Ejemplares similares

Reply to Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer
por: Guo, Jing, et al.
Publicado: (2019)

Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer
por: Guo, Jing, et al.
Publicado: (2019)

Next steps in the early detection of ovarian cancer
por: Bast, Robert C., et al.
Publicado: (2021)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

The Duplicitous Origin of Ovarian Cancer
por: Mor, Gil, et al.
Publicado: (2013)

Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
por: Walker, Christopher, et al.
Publicado: (2021)

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023)

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
por: Tcherkassova, Janneta, et al.
Publicado: (2011)

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021)

Early Detection of Ovarian Cancer
por: Badgwell, Donna, et al.
Publicado: (2007)

Early detection of ovarian cancer
por: Forstner, Rosemarie
Publicado: (2020)

Ovulation and extra-ovarian origin of ovarian cancer
por: Yang-Hartwich, Yang, et al.
Publicado: (2014)

Autoantibody Signature for the Serologic Detection of Ovarian Cancer
por: Anderson, Karen S., et al.
Publicado: (2014)

A roadmap for the early detection and diagnosis of cancer
por: Crosby, David, et al.
Publicado: (2020)

Early Detection Biomarkers for Ovarian Cancer
por: Sarojini, Sreeja, et al.
Publicado: (2012)

Nanobodies for the Early Detection of Ovarian Cancer
por: Tran, Lan-Huong, et al.
Publicado: (2022)

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
por: Sumi, Natalia J., et al.
Publicado: (2014)

Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model
por: Alvero, Ayesha B., et al.
Publicado: (2017)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171
por: Klein, Eric A., et al.
Publicado: (2022)

Advances in liquid biopsy approaches for early detection and monitoring of cancer
por: Babayan, Anna, et al.
Publicado: (2018)

Molecular Biomarkers for the Early Detection of Ovarian Cancer
por: Zhang, Ruiqian, et al.
Publicado: (2022)

TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214
por: Yin, Gang, et al.
Publicado: (2010)

Early detection of ovarian cancer: preliminary results of the Yale Early Detection Program.
por: Schwartz, P. E., et al.
Publicado: (1991)

Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
por: Chehade, Hussein, et al.
Publicado: (2022)

Practical early cancer detection: distinguishing stable from unstable genomes in pre-cancerous tissues
por: Killcoyne, Sarah, et al.
Publicado: (2020)

Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer
por: Salima, Siti, et al.
Publicado: (2022)

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative
por: Dunton, Charles J., et al.
Publicado: (2021)

Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
por: Cerne, Katarina, et al.
Publicado: (2019)

Osteopontin as a Tumor Marker in Ovarian Cancer
por: Rani, Shikha, et al.
Publicado: (2022)

Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
por: O’Mara, Tracy A., et al.
Publicado: (2020)

Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
por: Schwartz, P. E., et al.
Publicado: (1991)

Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels
por: Wang, Fei, et al.
Publicado: (2018)

The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?
por: Rolfo, Christian, et al.
Publicado: (2023)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells
por: Kim, Ki Hyung, et al.
Publicado: (2009)

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
por: Moelans, Cathy B, et al.
Publicado: (2019)

Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822
por: De Giorgi, Vincenzo, et al.
Publicado: (2022)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ub7jqsts642v3trfku2r7cgbj